|
86 |
The IoT edge: Elevating cleanroom monitoring to new heights in the era of Pharma 4.0
|
sureAssist |
2024-12-26 |
144 |
|
85 |
Water system qualification and requalifications: Considerations for microbial identification
|
sureAssist |
2024-12-26 |
143 |
|
84 |
2024 Emerging Trends In Cleanroom Technologies
|
sureAssist |
2024-12-26 |
138 |
|
83 |
Cleanrooms: What is the difference between clean-up period and recovery time?
|
sureAssist |
2024-12-26 |
164 |
|
82 |
The most common challenges with a cleanroom
|
sureAssist |
2024-12-26 |
142 |
|
81 |
The Real Cost Of Poor Quality — And What You Should Do About It
|
sureAssist |
2024-12-26 |
144 |
|
80 |
Draft Q&A Guidance Offers Roadmap For Biosimilar Post-approval Changes
|
sureAssist |
2024-12-26 |
139 |
|
79 |
10 points on how the FDA's CDER monitors the Quality of Medicinal Products
|
sureAssist |
2024-12-26 |
131 |
|
78 |
The difference between an ISO 17025 certified laboratory and an ISO 9001 one
|
sureAssist |
2024-12-26 |
127 |
|
77 |
This Week at FDA: Updated guidance on denying inspections and biosimilar interchangeability
|
sureAssist |
2024-12-26 |
131 |
